186 related articles for article (PubMed ID: 34935143)
1. Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool.
Nicastro N; Nencha U; Burkhard PR; Garibotto V
J Neurochem; 2023 Feb; 164(3):346-363. PubMed ID: 34935143
[TBL] [Abstract][Full Text] [Related]
2. Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism.
Hastings A; Cullinane P; Wrigley S; Revesz T; Morris HR; Dickson JC; Jaunmuktane Z; Warner TT; De Pablo-Fernández E
Neurology; 2024 Jun; 102(11):e209453. PubMed ID: 38759132
[TBL] [Abstract][Full Text] [Related]
3. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.
Booij J; Speelman JD; Horstink MW; Wolters EC
Eur J Nucl Med; 2001 Mar; 28(3):266-72. PubMed ID: 11315592
[TBL] [Abstract][Full Text] [Related]
4. Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders.
Akdemir ÜÖ; Bora Tokçaer A; Atay LÖ
Turk J Med Sci; 2021 Apr; 51(2):400-410. PubMed ID: 33237660
[TBL] [Abstract][Full Text] [Related]
5. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
[TBL] [Abstract][Full Text] [Related]
6. Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective study.
Nicastro N; Burkhard PR; Garibotto V
J Neurol Sci; 2018 Feb; 385():17-21. PubMed ID: 29406901
[TBL] [Abstract][Full Text] [Related]
7. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.
Cummings JL; Henchcliffe C; Schaier S; Simuni T; Waxman A; Kemp P
Brain; 2011 Nov; 134(Pt 11):3146-66. PubMed ID: 21810889
[TBL] [Abstract][Full Text] [Related]
8. Extrastriatal
Nicastro N; Fleury V; Broc N; Burkhard PR; Garibotto V
Parkinsonism Relat Disord; 2020 Sep; 78():38-43. PubMed ID: 32698058
[TBL] [Abstract][Full Text] [Related]
9. Molecular Imaging of the Dopamine Transporter.
Palermo G; Ceravolo R
Cells; 2019 Aug; 8(8):. PubMed ID: 31405186
[TBL] [Abstract][Full Text] [Related]
10. SPECT imaging of the dopaminergic system in (premotor) Parkinson's disease.
Booij J; Knol RJ
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S425-8. PubMed ID: 18267276
[TBL] [Abstract][Full Text] [Related]
11. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
[TBL] [Abstract][Full Text] [Related]
12. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism.
Booij J; Tissingh G; Winogrodzka A; van Royen EA
Eur J Nucl Med; 1999 Feb; 26(2):171-82. PubMed ID: 9933352
[TBL] [Abstract][Full Text] [Related]
13. Dopamine transporter (DAT) imaging in Parkinson's disease and related disorders.
Brücke T; Brücke C
J Neural Transm (Vienna); 2022 Jun; 129(5-6):581-594. PubMed ID: 34910248
[TBL] [Abstract][Full Text] [Related]
14. I
Quintas S; Sanles-Falagan R; Berbís MÁ
Mov Disord Clin Pract; 2024 Jun; 11(6):613-625. PubMed ID: 38693679
[TBL] [Abstract][Full Text] [Related]
15. Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice.
Ba F; Martin WR
Parkinsonism Relat Disord; 2015 Feb; 21(2):87-94. PubMed ID: 25487733
[TBL] [Abstract][Full Text] [Related]
16. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
17. Role of DAT-SPECT in the diagnostic work up of parkinsonism.
Scherfler C; Schwarz J; Antonini A; Grosset D; Valldeoriola F; Marek K; Oertel W; Tolosa E; Lees AJ; Poewe W
Mov Disord; 2007 Jul; 22(9):1229-38. PubMed ID: 17486648
[TBL] [Abstract][Full Text] [Related]
18. Distinctive regional asymmetry in dopaminergic and serotoninergic dysfunction in degenerative Parkinsonisms.
Takahashi R; Ishii K; Sousa K; Marumoto K; Kashibayashi T; Fujita J; Yokoyama K
J Neurol Sci; 2021 Apr; 423():117363. PubMed ID: 33640580
[TBL] [Abstract][Full Text] [Related]
19. Imaging Dopaminergic Neurotransmission in Neurodegenerative Disorders.
Wallert ED; van de Giessen E; Knol RJJ; Beudel M; de Bie RMA; Booij J
J Nucl Med; 2022 Jun; 63(Suppl 1):27S-32S. PubMed ID: 35649651
[TBL] [Abstract][Full Text] [Related]
20. The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2.
Booth TC; Nathan M; Waldman AD; Quigley AM; Schapira AH; Buscombe J
AJNR Am J Neuroradiol; 2015 Feb; 36(2):236-44. PubMed ID: 24924549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
